KoreaBIO Releases Policy Recommendations Report on Biomaterials
Proposes Policy Initiatives, Including Expanded Demonstration and Mass-Production Infrastructure

A recommendation has been made to strengthen the industrialization support system that connects research and development (R&D) achievements to actual product manufacturing and market entry, in order to enhance the competitiveness of Korea's biomaterials industry.


On November 19, the Korea Biotechnology Industry Organization (KoreaBIO) published a report titled "Paradigm Shift and Policy Recommendations for a Sustainable Biomaterials Industry," analyzing domestic and international trends in the biomaterials industry and case studies of major companies.


ChatGPT-Generated Images

ChatGPT-Generated Images

View original image

Biomaterials are materials developed using biological resources such as plants, microorganisms, and proteins, and are used across various industries, including food, cosmetics, and agriculture. Recently, advances in artificial intelligence (AI), synthetic biology, and biomanufacturing technologies have driven technological innovation throughout the entire process, from material development to production.


The report found that, for the sustained growth of Korea's biomaterials industry, support for commercialization linked to actual industry demand is needed, beyond support focused on technology development. It noted that, although support for technology development and commercialization has expanded, companies still face difficulties in validating the materials they develop, establishing mass-production systems, and entering the market.


To address these challenges, the report proposed six major policy initiatives: ▲standardizing biomaterial raw materials and establishing supply chains; ▲enhancing an industrialization support system based on market demand; ▲expanding infrastructure for demonstration and production scale-up; ▲improving regulatory and evaluation frameworks for new types of biomaterials; ▲building an AI-based innovation ecosystem for biomaterials; and △fostering investment and the industrial ecosystem.


In particular, the report emphasized the need to expand collaborative R&D and proof-of-concept (PoC) projects involving companies that will use the materials from the early stages of technology development. The goal is to establish a step-by-step support system that carries developed materials from performance validation through mass production and product development, connecting research outcomes to actual business opportunities.



"Biomaterials have growing potential for use in various industries, including food, cosmetics, and agriculture, and advances in AI and biomanufacturing technologies are expanding industrial opportunities," said Oh Ki-hwan, head of the Bioeconomy Research Center at the Korea Biotechnology Industry Organization. "Policy efforts are needed to link collaboration with companies that will use the materials, demonstration and scale-up infrastructure, regulatory support, and investment support, so that Korean companies can turn the technologies they have developed into actual products and businesses."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing